29 April 2020 - An experimental Australian vaccine for COVID-19 has generated immunity levels in preclinical trials exceeding those recorded in people who have recovered from the disease.

The findings released Wednesday entrench the molecular clamp technology developed by scientists at the University of Queensland as among the most promising in the world to combat coronavirus.

After being tested on animals in the lab, the prototype drug was shown to generate high levels of antibodies against the virus.

Read The Australian article